![]() |
Volumn 17, Issue 4, 2000, Pages 304-309
|
Oral griseofulvin remains the treatment of choice for tinea capitis in children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
AMPHOTERICIN B;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIFUNGAL AGENT;
ANTIVIRUS AGENT;
CIMETIDINE;
CLARITHROMYCIN;
CYCLOSPORIN;
DIGOXIN;
FLUCONAZOLE;
GRISEOFULVIN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
ITRACONAZOLE;
KETOCONAZOLE;
ORAL CONTRACEPTIVE AGENT;
PHENYTOIN;
RANITIDINE;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
TERBINAFINE;
THEOPHYLLINE;
TOLBUTAMIDE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIMIPRAMINE;
UNINDEXED DRUG;
WARFARIN;
ZIDOVUDINE;
ARTICLE;
CHILD;
CHILDHOOD DISEASE;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG PREFERENCE;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TOXICITY;
HUMAN;
LIVER TOXICITY;
PRIORITY JOURNAL;
TINEA;
TINEA CAPITIS;
ADMINISTRATION, ORAL;
ANTIBIOTICS, ANTIFUNGAL;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
GRISEOFULVIN;
HUMANS;
TINEA CAPITIS;
TREATMENT OUTCOME;
TRICHOPHYTON;
|
EID: 0033864803
PISSN: 07368046
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1470.2000.01784.x Document Type: Article |
Times cited : (71)
|
References (34)
|